Jan 29, 2020 - Novartis AG (NYSE:NVS) Q4 2019 Results Earnings Conference Call January 29, 2020, 08:00 AM ET Company Participants Samir Shah - Global Head of IR Vasant Narasimhan - CEO Harry Kirsch - CFO Marie-Franc
Jan 29, 2020 - Incyte (INCY) posts positive top-line results from late-stage TRuE-AD2 study on ruxolitinib cream to treat adolescent and adult patients with atopic dermatitis. The study achieves its main goal.
Jan 30, 2020 - CLB earnings call for the period ending December 31, 2019.
Jan 31, 2020 - Top Stock Analyst Reports for Microsoft, Facebook & Novartis
Jan 31, 2020 - Lilly (LLY), Pfizer (PFE) and Novartis (NVS) announce Q4 results.
Feb 03, 2020 - Glaxo's (GSK) Vaccines and Respiratory segments are likely to have driven sales in the fourth quarter.
Feb 04, 2020 - Ferrari N.V. (NYSE:RACE) Q4 2019 Earnings Conference Call February 04, 2020, 09:00 AM ET Company Participants Nicoletta Russo - Head IR Louis Camilleri - CEO Antonio Piccon - CFO Conference Call Parti
Feb 05, 2020 - MELEXIS NV IEPER (OTC:MLXSF) Q4 2019 Earnings Conference Call February 05, 2020 4:30 AM ET Company Participants Françoise Chombar – Chief Executive Officer Karen Van Griensven – Chief Financial Office
Feb 10, 2020 - Roche's (RHHBY) Alzheimer's disease drug fails to meet primary endpoint in a phase II/III study.
Feb 12, 2020 - The following slide deck was published by Telenet Group Holding NV in conjunction with their 2019 Q4 earnings call.